NCT02202304

Brief Summary

Cervitec, a chlorhexidine based varnished has been proven to reduce caries risk in younger populations. This study wants to investigate if the use of this product would reduce the risk of losing abutment teeth on patients that are wearing partial dentures as the literature has proven that these teeth are more prone to caries and periodontal disease. The primary objectives of this research project are to:

  1. 1.Assess if the topical application of CHX/thymol varnish every three months on partial denture abutment teeth results in a clinicallu significant decrease in any loss of attachment compared to no application, and
  2. 2.Assess if the topical application of CHX/thymol vanirhs every three months on partial denture abutment teeth results in a clinically significant decrease in carious lesion development or progression compared to no application.
  3. 3.Bleeding on probing (BoP).
  4. 4.Plaque formation.
  5. 5.Periodontal pocket depths.
  6. 6.Microbial composition and GCF cytokine profile of the sub gingival environment.
  7. 7.The patients self perception of oral health.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2017

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 24, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 29, 2014

Completed
3.1 years until next milestone

Study Start

First participant enrolled

September 10, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2019

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2020

Completed
Last Updated

May 15, 2017

Status Verified

May 1, 2017

Enrollment Period

2 years

First QC Date

July 24, 2014

Last Update Submit

May 12, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assess if the topical application of CHX/thymol varnish every three months on partial denture abutment teeth results in a clinicallu significant decrease in any loss of attachment compared to no application

    we will measure the Loss of Attachment (LoA) around each abutment tooth at 6 points

    Assesed at the begining, at 12 months and at 24 months

Secondary Outcomes (1)

  • Assess if the topical application of CHX/thymol vanirhs every three months on partial denture abutment teeth results in a clinically significant decrease in carious lesion development or progression compared to no application

    at the beginning, at 12 months and at 24 months

Study Arms (2)

Chlorhexidine/Thymol varnish

EXPERIMENTAL

Participants to the study will receive an application of either the placebo or the product being studied every 3 months. This will be applied on all abutment teeth using a microbrush by "painting" it over the surfaces of these teeth.

Drug: Chlorhexidine/Thymol varnish

Placebo varnish

PLACEBO COMPARATOR

Participants to the study will receive an application of either the placebo or the product being studied every 3 months. This will be applied on all abutment teeth using a microbrush and "painting" it on all the surfaces of these teeth..

Drug: Chlorhexidine/Thymol varnish

Interventions

This will be applied on abutment teeth on partial denture wearers every 3 months during a period of 2 years.

Also known as: Cervitec Plus (1% chlorhexidine plus 1% thymol)
Chlorhexidine/Thymol varnishPlacebo varnish

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients that are going to have a new denture fitted at the Dental School of the University of Aberdeen and Penninsula Dental School.
  • Patients aged 18 years or over.

You may not qualify if:

  • Patients that already have a denture.
  • Patients that are taking antibiotics.
  • Patients allergic to any of the components of the products.
  • Pregnant women.
  • Severe systemic illness.
  • Patient with active periodontal disease (BoP and pockets ≥3mm) on abutment teeth.
  • Presence of caries on abutment teeth.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Aberdeen

Aberdeen, Aberdeenshire, AB252ZR, United Kingdom

Location

Related Publications (4)

  • Baca P, Clavero J, Baca AP, Gonzalez-Rodriguez MP, Bravo M, Valderrama MJ. Effect of chlorhexidine-thymol varnish on root caries in a geriatric population: a randomized double-blind clinical trial. J Dent. 2009 Sep;37(9):679-85. doi: 10.1016/j.jdent.2009.05.001. Epub 2009 May 13.

    PMID: 19497653BACKGROUND
  • Tanaka J, Tanaka M, Kawazoe T. Longitudinal research on the oral environment of elderly wearing fixed or removable prostheses. J Prosthodont Res. 2009 Apr;53(2):83-8. doi: 10.1016/j.jpor.2008.10.003. Epub 2009 Jan 10.

    PMID: 19318078BACKGROUND
  • Shimura Y, Wadachi J, Nakamura T, Mizutani H, Igarashi Y. Influence of removable partial dentures on the formation of dental plaque on abutment teeth. J Prosthodont Res. 2010 Jan;54(1):29-35. doi: 10.1016/j.jpor.2009.08.003. Epub 2009 Oct 8.

    PMID: 19818702BACKGROUND
  • Clavero J, Baca P, Paloma Gonzalez M, Valderrama MJ. Efficacy of chlorhexidine-thymol varnish (Cervitec) against plaque accumulation and gingival inflammation in a geriatric population. Gerodontology. 2006 Mar;23(1):43-7. doi: 10.1111/j.1741-2358.2006.00085.x.

    PMID: 16433641BACKGROUND

MeSH Terms

Conditions

Periodontal Diseases

Interventions

Chlorhexidinechlorhexidine, thymol drug combinationThymol

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic ChemicalsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsMonoterpenesTerpenes

Study Officials

  • Rosa Moreno Lopez, BDS

    University of Aberdeen

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

July 24, 2014

First Posted

July 29, 2014

Study Start

September 10, 2017

Primary Completion

September 10, 2019

Study Completion

December 10, 2020

Last Updated

May 15, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will share

within 6 months

Locations